ArticleChinese medical journal2024

Safety and efficacy of a novel responsive neurostimulation system in China for drug-refractory focal epilepsy: The first-in-man study.

Kailiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.